Adobe Stock 502062990
Adobe Stock 502062990

Biocatalysts Ltd Introduce Unique Protease Platform for the Manufacture of High Value Collagen Peptides

Published 28 May 2024
Home/ Media & Resources/ Biocatalysts Ltd Introduce Unique Protease Platform for the Manufacture of High Value Collagen Peptides

Biocatalysts Ltd, a leading expert in speciality enzymes, proudly announces the launch of two unique protease enzymes designed for the effective hydrolysis of extracted collagen to produce low molecular weight and neutral tasting collagen peptides. Furthermore, improving the flavour, functionality and processibility of different proteins across many industries.

Harnessing decades of expertise in enzyme development, Biocatalysts Ltd introduces Promod™ 327L and Promod™ 295L, the latest additions to its portfolio of high-performance enzymes. These unique proteases deliver significant efficiency and precision in collagen processing, offering improved quality and yields of extracted collagen, reducing time of extraction and prevention of undesired taste and colour generation of collagen during processing.

Collagen is an exciting growing market for Biocatalysts with uses in dietary supplements, cosmetics, and biomedical materials with a growth rate of 11.6% CAGR. These new products are part of an ongoing commitment to the development of a unique protease platform, the unparalleled efficacy and versatility of Promod™ 327L and Promod™ 295L opens new avenues for optimising taste, texture and processibility to deliver superior high value collagen peptides with desired application functionality

— Daren Bryce, VP for Food & Pharmaceuticals at Biocatalysts Ltd

For more information about Promod™ 327L and Promod™ 295L, and Biocatalysts Ltd.’s comprehensive range of enzyme solutions, click below:

Sign up to our newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.